FI822260L - Basiska acylamider av (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)-metanoner - Google Patents

Basiska acylamider av (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)-metanoner

Info

Publication number
FI822260L
FI822260L FI822260A FI822260A FI822260L FI 822260 L FI822260 L FI 822260L FI 822260 A FI822260 A FI 822260A FI 822260 A FI822260 A FI 822260A FI 822260 L FI822260 L FI 822260L
Authority
FI
Finland
Prior art keywords
methanoner
dialkylpyrazol
acylamider
aryl
amino
Prior art date
Application number
FI822260A
Other languages
English (en)
Finnish (fi)
Other versions
FI822260A0 (fi
Inventor
Horace Albert Dewald
Lawrence David Wise
David M Lustgarten
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI822260A0 publication Critical patent/FI822260A0/fi
Publication of FI822260L publication Critical patent/FI822260L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • C07D231/40Acylated on said nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI822260A 1981-06-26 1982-06-23 Basiska acylamider av (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)-metanoner FI822260L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27757781A 1981-06-26 1981-06-26

Publications (2)

Publication Number Publication Date
FI822260A0 FI822260A0 (fi) 1982-06-23
FI822260L true FI822260L (fi) 1982-12-27

Family

ID=23061477

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822260A FI822260L (fi) 1981-06-26 1982-06-23 Basiska acylamider av (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)-metanoner

Country Status (11)

Country Link
EP (1) EP0068806A3 (ja)
JP (1) JPS584771A (ja)
AU (1) AU8515182A (ja)
DD (1) DD202547A5 (ja)
DK (1) DK282882A (ja)
ES (3) ES8304550A1 (ja)
FI (1) FI822260L (ja)
GR (1) GR76155B (ja)
IL (1) IL66109A0 (ja)
NO (1) NO822100L (ja)
ZA (1) ZA824468B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
DE3600950A1 (de) * 1986-01-15 1987-07-16 Bayer Ag 5-acylamido-1-aryl-pyrazole
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558605A (en) * 1969-05-14 1971-01-26 Parke Davis & Co Pyrazolo(3,4-e)(1,4)diazepin-7-(1h)-one compounds
BE735597A (en) * 1969-07-03 1970-01-05 1-aryl 3 4-opt subst 5-aminoalkanoylamino-pyrazoles
FR2100973A1 (en) * 1970-07-30 1972-03-24 Yoshitomi Pharmaceutical 5-Aminopyrazoles - with analgesic, antiinflammatory and muscle relaxant activity
US3886143A (en) * 1974-01-21 1975-05-27 Parke Davis & Co Oxazolo {8 3,2-D{9 pyrazolo{8 4,3-F{9 {0 {8 1,4{9 diazepin-6(7H)-one compounds

Also Published As

Publication number Publication date
ES513399A0 (es) 1983-03-01
FI822260A0 (fi) 1982-06-23
ES8305350A1 (es) 1983-04-01
JPS584771A (ja) 1983-01-11
ES513398A0 (es) 1983-03-01
EP0068806A2 (en) 1983-01-05
ES8304550A1 (es) 1983-03-01
GR76155B (ja) 1984-08-03
AU8515182A (en) 1983-01-06
NO822100L (no) 1982-12-27
ES8304551A1 (es) 1983-03-01
ZA824468B (en) 1983-04-27
DK282882A (da) 1982-12-27
ES513375A0 (es) 1983-04-01
IL66109A0 (en) 1982-09-30
EP0068806A3 (en) 1983-08-10
DD202547A5 (de) 1983-09-21

Similar Documents

Publication Publication Date Title
FI74024B (fi) Foerfarande foer framstaellning av d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
FI77053B (fi) Foerfarande foer selektiv hydrering av maongfaldigt omaettade kolvaeten i kolvaeteblandningar.
FI874862A0 (fi) Anordning foer matning av plastmaterial till ett extruderhuvud.
FI844400A0 (fi) Kupning av glaskroppar pao ett formningsbord bestaoende av roterbara delar.
FI78593B (fi) Kylanordning av teleteknisk utrustning.
FI77039B (fi) Foerfarande foer framstaellning av 7-(2-aminotiazolyl)cefalosporinderivat.
IT8223146A0 (it) Benzotiazolin-composti.
FI834285A (fi) Kopplingsanordning foer justering av effekt.
IT8224195A0 (it) Composti triarilboranoisociano-metallici.
FI822260A0 (fi) Basiska acylamider av (5-amino-1,3-dialkylpyrazol-4-yl)(aryl)-metanoner
FI851651A0 (fi) Transduktor foer omvandlande av elsignal till trycksignal.
IT8219937A0 (it) Verricello passante.
NO811213L (no) Vibrasjonsisolator.
FI824131L (fi) Anordning foer foerankring av last.
FI831262L (fi) Foerbaettrat foerfarande foer framstaellning av 6-beta-substituerad penicillanoyloximetyl-penicillanat-1,1-dioxid
FI830839L (fi) Nytt foerfarande foer framstaellning av difenyl-3,4-metyl-5-pyrazolderivat
FI77045B (fi) Foergrenade amider av l-aspartyl-d-aminosyrapeptider.
FI903791A0 (fi) Foerfarande foer framstaellning av farmakologiskt verksamma dihydroxifenyletylaminer.
FI874107A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara piperidinderivat.
FI851548L (fi) Analogfoerfarande foer framstaellning av terapeutiskt anvaendbara platina-diaminkomplex.
FI811215A0 (fi) Loesning av sysselsaettnings- problemet.
FI854831A (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara tetrahydro-1h-pyridoindolderivat.
FI874436A0 (fi) Foerfarande foer framstaellning av optiskt aktiva penemer.
FI860790A (fi) Foerfarande foer framstaellning av ergopeptinderivat.
FI864866A0 (fi) Mellanprodukter foer framstaellning av vaerdefulla bentsamidoderivater.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY